4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-001931
PRESIDENT, CEO sold 19,293 shares at $40.13 ($774,245)
- PRESIDENT, CEO acquired 19,293 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dayno Jeffrey M. PRESIDENT, CEO | 2025-01-21 | Option exercise 10b5-1 | +19,293 | $8.22 | $158,588 | 19,293 | D |
| Dayno Jeffrey M. PRESIDENT, CEO | 2025-01-21 | Sale 10b5-1 | −19,293 | $40.13 | $774,245 | 0 | D |
| Derivatives | |||||||
| Dayno Jeffrey M. PRESIDENT, CEO | 2025-01-21 | Option exercise · Stock Option 10b5-1 | −3,470 | 20,000 | D | ||
| Dayno Jeffrey M. PRESIDENT, CEO | 2025-01-21 | Option exercise · Stock Option 10b5-1 | −6,086 | 0 | D | ||
| Dayno Jeffrey M. PRESIDENT, CEO | 2025-01-21 | Option exercise · Stock Option 10b5-1 | −9,737 | 2,435 | D | ||
| Open-market sales · 19,293 sh · avg $40.13 · $774,245 | |||||||
Loading xslF345X05/form4-01232025_090139.xml…